netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 18 of 18


Details
LDL Link Added : MHRA Drug Safety Update June 2019: Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome : https://www.gov.uk/drug-safety-update/direct-acting-oral-anticoagulants-d
05/07/2023 12:54:15
(ebeavers )
LDL Link Added : MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) : https://www.gov.uk/drug-safety-update/new-oral-anticoagulants-apixaban-eliquis-dabigatran-pradaxa-and
05/07/2023 12:49:13
(ebeavers )
LDL Link Added : MHRA Drug Safety Alert June 2020: Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, including availability of reversal agents : https://www.gov.uk/drug-safety-update/direct-acting-oral-anticoagulants-doacs-reminder-of-blee
05/07/2023 12:37:15
(ebeavers )
LDL Link Added : MHRA Drug Safety Update Oct 2018: Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement: increase in all-cause mortality, thromboembolic and bleeding events in a clinical trial : https://www.gov.uk/drug-safety-update/rivar
05/07/2023 12:31:28
(ebeavers )
LDL Link Added : MHRA Drug Safety Update July 2019: Rivaroxaban (Xarelto▼): reminder that 15 mg and 20 mg tablets should be taken with food : https://www.gov.uk/drug-safety-update/rivaroxaban-xarelto-reminder-that-15-mg-and-20-mg-tablets-should-be-taken
05/07/2023 12:30:31
(ebeavers )
UPD Rivaroxaban updated
13/08/2021 16:22:09
(DavidS )
UPD Rivaroxaban updated
24/05/2021 15:06:52
(DavidS )
LDL Link Added : NICE TA607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease : https://www.nice.org.uk/guidance/ta607
13/02/2020 14:48:59
(DavidS )
UPD Rivaroxaban b
26/01/2017 18:08:59
(LoweryM )
UPD Rivaroxaban b
12/01/2017 11:35:35
(WhitehallJ )
UPD Published from Draft Mode
12/01/2017 11:05:36
(WhitehallJ )
LDL Link Added : NICE TA335: Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome : https://www.nice.org.uk/guidance/ta335
12/01/2017 10:52:09
(WhitehallJ )
LDL Link Added : NICE TA287: Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism : https://www.nice.org.uk/guidance/ta287
12/01/2017 10:51:06
(WhitehallJ )
LDL Link Added : NICE TA261: Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism : https://www.nice.org.uk/guidance/ta261
12/01/2017 10:50:24
(WhitehallJ )
LDL Link Added : NICE TA256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation : https://www.nice.org.uk/guidance/ta256
12/01/2017 10:49:50
(WhitehallJ )
LDL Link Added : NICE TA170: Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults : https://www.nice.org.uk/guidance/ta170
12/01/2017 10:49:00
(WhitehallJ )
UPD Rivaroxaban b
12/01/2017 10:47:46
(WhitehallJ )
UPD Rivaroxaban Build
24/11/2016 11:16:56
(ClarkH )

 

 
netFormulary